King Luther Capital Management Corp Boston Scientific Corp Transaction History

King Luther Capital Management Corp

$23.9 Billion
Q3 2025

A detailed history of King Luther Capital Management Corp transactions in Boston Scientific Corp stock. As of the latest transaction made, King Luther Capital Management Corp holds 46,851 shares of BSX stock, worth $4.81 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

46,851

Previous 10,397 350.62%

Holding current value

$4.81 Million

Previous $1.12 Million 309.86%

% of portfolio

0.02%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	BUY	$97.03 - $108.14 $3.54 Million - $3.94 Million	36,454 Added 350.62%	46,851 $4.57 Million
Q2 2025 Aug 07, 2025	BUY	$89.7 - $107.41 $7,803 - $9,344	87 Added 0.84%	10,397 $1.12 Million
Q1 2025 May 12, 2025	BUY	$89.38 - $106.18 $5,362 - $6,370	60 Added 0.59%	10,310 $1.04 Million
Q4 2024 Feb 07, 2025	SELL	$83.62 - $91.5 $1,087 - $1,189	-13 Reduced 0.13%	10,250 $915,000
Q3 2024 Nov 08, 2024	BUY	$72.96 - $84.0 $5,326 - $6,132	73 Added 0.72%	10,263 $860,000

Q3 2023 Nov 13, 2023	SELL	$50.19 - $54.68 $8,231 - $8,967	-164 Reduced 1.58%	10,190 $538,000
Q2 2023 Aug 10, 2023	BUY	$49.72 - $54.64 $3,927 - $4,316	79 Added 0.77%	10,354 $560,000
Q1 2023 May 11, 2023	BUY	$45.09 - $50.03 $1,127 - $1,250	25 Added 0.24%	10,275 $514,000
Q4 2022 Feb 13, 2023	SELL	$39.56 - $47.22 $5,894 - $7,035	-149 Reduced 1.43%	10,250 $474,000
Q2 2022 Aug 11, 2022	SELL	$35.24 - $47.1 $18,959 - $25,339	-538 Reduced 4.92%	10,399 $388,000
Q1 2022 May 11, 2022	BUY	$40.9 - $45.1 $9,775 - $10,778	239 Added 2.23%	10,937 $484,000
Q4 2021 Feb 14, 2022	SELL	$38.07 - $44.87 $6,015 - $7,089	-158 Reduced 1.46%	10,698 $454,000
Q3 2021 Nov 10, 2021	BUY	$41.23 - $45.88 $8,493 - $9,451	206 Added 1.93%	10,856 $471,000
Q2 2021 Aug 13, 2021	SELL	$38.58 - $44.24 $2,584 - $2,964	-67 Reduced 0.63%	10,650 $455,000
Q1 2021 May 12, 2021	SELL	$35.27 - $39.67 $9,734 - $10,948	-276 Reduced 2.51%	10,717 $414,000
Q4 2020 Feb 10, 2021	SELL	$33.15 - $41.97 $515,117 - $652,171	-15,539 Reduced 58.57%	10,993 $395,000
Q2 2020 Aug 12, 2020	SELL	$30.19 - $39.11 $41,662 - $53,971	-1,380 Reduced 4.94%	26,532 $932,000
Q1 2020 May 13, 2020	SELL	$25.83 - $45.71 $17,435 - $30,854	-675 Reduced 2.36%	27,912 $911,000
Q4 2019 Feb 12, 2020	BUY	$37.87 - $45.37 $10,641 - $12,748	281 Added 0.99%	28,587 $1.29 Million
Q3 2019 Nov 12, 2019	BUY	$40.31 - $43.45 $403,503 - $434,934	10,010 Added 54.71%	28,306 $1.15 Million
Q2 2019 Aug 12, 2019	SELL	$34.91 - $42.98 $749,378 - $922,608	-21,466 Reduced 53.99%	18,296 $786,000
Q4 2018 Feb 12, 2019	BUY	$31.73 - $39.04 $698 - $858	22 Added 0.06%	39,762 $1.41 Million
Q3 2018 Nov 13, 2018	BUY	$32.83 - $38.63 $499,180 - $587,369	15,205 Added 61.97%	39,740 $1.53 Million
Q2 2018 Aug 13, 2018	BUY	$26.84 - $34.32 $658,519 - $842,041	24,535 New	24,535 $802,000

Others Institutions Holding BSX

# of Institutions

1,953

Shares Held

1.27B

Call Options Held

10.8M

Put Options Held

8.94M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $147B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of King Luther Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on King Luther Capital Management Corp with notifications on news.

Account

King Luther Capital Management Corp Boston Scientific Corp Transaction History